4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis.

about

Association between maternal, fetal and paternal MTHFR gene C677T and A1298C polymorphisms and risk of recurrent pregnancy loss: a comprehensive evaluation.

P2860

Q35831020-3E986F4B-0ACD-42E8-8433-058C7A84F35B

P2860

4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis.

Item

http://www.wikidata.org/entity/Q38391627

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

4G/5G polymorphism of plasmino ...... ese patients: a meta-analysis.

@en

type

Item

label

4G/5G polymorphism of plasmino ...... ese patients: a meta-analysis.

@en

prefLabel

4G/5G polymorphism of plasmino ...... ese patients: a meta-analysis.

@en

P1476

4G/5G polymorphism of plasmino ...... ese patients: a meta-analysis.

@en

P2093

Li-Hong Wang

http://www.w3.org/2001/XMLSchema#string

Li-Mei Wang

http://www.w3.org/2001/XMLSchema#string

Na Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.

Polycystic ovary syndrome and cardiovascular disease: a premature association?

A practical approach to the diagnosis of polycystic ovary syndrome.

4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.

Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.

The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.

Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.

Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.

A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome.

P2888

s00404-015-3678-1

P304

683-686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S00404-015-3678-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013639765

http://www.w3.org/2001/XMLSchema#string

P698

25731152

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis.

about

P2860

P2860

4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921